Literature DB >> 31498502

Nationwide validation study of diagnostic algorithms for inflammatory bowel disease in Korean National Health Insurance Service database.

Chang Kyun Lee1, Hyo Jung Ha1, Shin Ju Oh1, Jung-Wook Kim1, Jung Kuk Lee2, Hyun-Soo Kim3, Soon Man Yoon4, Sang-Bum Kang5, Eun Soo Kim6, Tae Oh Kim7, Soo-Young Na8, Jun Lee9, Sang-Wook Kim10, Hoon Sup Koo11, Byung Kyu Park12, Han Hee Lee13, Eun Sun Kim14, Jae Jun Park15, Min Seob Kwak16, Jae Myung Cha16, Byong Duk Ye17, Chang Hwan Choi18, Hyo Jong Kim1.   

Abstract

BACKGROUND AND AIM: We conducted a nationwide validation study of diagnostic algorithms to identify cases of inflammatory bowel disease (IBD) within the Korea National Health Insurance System (NHIS) database.
METHOD: Using the NHIS dataset, we developed 44 algorithms combining the International Classification of Diseases (ICD)-10 codes, codes for Rare and Intractable Diseases (RID) registration and claims data for health care encounters, and pharmaceutical prescriptions for IBD-specific drugs. For each algorithm, we compared the case identification results from electronic medical records data with the gold standard (chart-based diagnosis). A multiple sampling test verified the validation results from the entire study population.
RESULTS: A random nationwide sample of 1697 patients (848 potential cases and 849 negative control cases) from 17 hospitals were included for validation. A combination of the ICD-10 code, ≥ 1 claims for health care encounters, and ≥ 1 prescription claims (reference algorithm) achieved excellent performance (sensitivity, 93.1% [95% confidence interval 91-94.7]; specificity, 98.1% [96.9-98.8]; positive predictive value, 97.5% [96.1-98.5]; negative predictive value, 94.5% [92.8-95.8]) with the lowest error rate (4.2% [3.3-5.3]). The multiple sampling test confirmed that the reference algorithm achieves the best performance regarding IBD diagnosis. Algorithms including the RID registration codes exhibited poorer performance compared with that of the reference algorithm, particularly for the diagnosis of patients affiliated with secondary hospitals. The performance of the reference algorithm showed no statistical difference depending on the hospital volume or IBD type, with P-value < 0.05.
CONCLUSIONS: We strongly recommend the reference algorithm as a uniform standard operational definition for future studies using the NHIS database.
© 2019 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  administrative claims, health care; diagnostic algorithm; inflammatory bowel disease; operational definition

Mesh:

Year:  2019        PMID: 31498502     DOI: 10.1111/jgh.14855

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  8 in total

1.  Validity of Diagnostic Algorithms for Inflammatory Bowel Disease in Japanese Hospital Claims Data.

Authors:  Sayumi Takahashi; Taku Obara; Yoichi Kakuta; Yusuke Shimoyama; Takeo Naito; Rintaro Moroi; Masatake Kuroha; Hisashi Shiga; Yoshitaka Kinouchi; Atsushi Masamune
Journal:  Int J Environ Res Public Health       Date:  2022-06-28       Impact factor: 4.614

2.  Shift to a Younger Age and Regional Differences in Inflammatory Bowel Disease in Korea: Using Healthcare Administrative Data.

Authors:  Seo-Hee Kim; Yujin Park; Seong Pyo Kim; Sung Hee Lee; Seak Hee Oh; Suk-Kyun Yang; Hyung-Jin Yoon; Kyung Mo Kim
Journal:  Dig Dis Sci       Date:  2022-01-30       Impact factor: 3.487

3.  Venous Thromboembolism Risk in Asian Patients with Inflammatory Bowel Disease: A Population-Based Nationwide Inception Cohort Study.

Authors:  Su Young Kim; Yeon Seo Cho; Hyun-Soo Kim; Jung Kuk Lee; Hee Man Kim; Hong Jun Park; Hyunil Kim; Jihoon Kim; Dae Ryong Kang
Journal:  Gut Liver       Date:  2021-11-18       Impact factor: 4.321

4.  Performance evaluation of case definitions of type 1 diabetes for health insurance claims data in Japan.

Authors:  Tasuku Okui; Chinatsu Nojiri; Shinichiro Kimura; Kentaro Abe; Sayaka Maeno; Masae Minami; Yasutaka Maeda; Naoko Tajima; Tomoyuki Kawamura; Naoki Nakashima
Journal:  BMC Med Inform Decis Mak       Date:  2021-02-11       Impact factor: 2.796

5.  Additive interaction of mid- to late-life depression and cerebrovascular disease on the risk of dementia: a nationwide population-based cohort study.

Authors:  Yoo Jin Jang; Cinoo Kang; Ho Kim; Doh Kwan Kim; Woojae Myung; Shinn-Won Lim; Young Kyung Moon
Journal:  Alzheimers Res Ther       Date:  2021-03-16       Impact factor: 6.982

6.  Sex differences in the prognosis of patients with hypertrophic cardiomyopathy.

Authors:  Minkwan Kim; Bongsung Kim; You-Jung Choi; Hyun-Jung Lee; Heesun Lee; Jun-Bean Park; Seung-Pyo Lee; Kyung-Do Han; Yong-Jin Kim; Hyung-Kwan Kim
Journal:  Sci Rep       Date:  2021-03-01       Impact factor: 4.379

Review 7.  Inflammatory bowel disease in Korea: epidemiology and pathophysiology.

Authors:  Jung Won Lee; Chang Soo Eun
Journal:  Korean J Intern Med       Date:  2022-07-29       Impact factor: 3.165

8.  Association of Preterm Birth with Inflammatory Bowel Disease and Salivary Gland Disease: Machine Learning Analysis Using National Health Insurance Data.

Authors:  Kwang-Sig Lee; Eun Sun Kim; In-Seok Song; Hae-In Kim; Ki Hoon Ahn
Journal:  Int J Environ Res Public Health       Date:  2022-03-05       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.